Novel Cdk2/Cdk9 Inhibitor Fadraciclib Targets Cell Survival and Dna Damage Pathways and Synergizes with Encorafenib in Human Colorectal Cancer Cells with Braf(V600E)

AuthID
P-019-V60
4
Author(s)
Mohiuddin, M
·
Póvoa, V
·
Sinicrope, FA
Tipo de Documento
Article
Year published
2025
Publicado
in ONCOGENESIS, ISSN: 2157-9024
Volume: 14, Número: 1
Indexing
Publication Identifiers
Pubmed: 40769976
SCOPUS: 2-s2.0-105012717084
Wos: WOS:001545149400001
Source Identifiers
ISSN: 2157-9024
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.